Aug 2026· European Archives of Psychiatry and Clinical Neuroscience· 0 citations· 24 references
Medicine
TL;DR
Genetic evidence suggesting medication-specific associations between antidepressant use liability and T2D susceptibility is provided, highlighting that the metabolic effects of individual antidepressants may vary, thus, warranting further studies to determine the clinical relevance of the findings.
Genetic evidence of potential associations between antidepressant use and increased risks of Hashimoto's thyroiditis and hypothyroidism is provided, and support consideration of thyroidfunction monitoring in patients receiving antidepressant treatment, particularly those with pre-existing thyroid risk factors.
Yingxian Ling, Qi-Song Chen· Actas espanolas de psiquiatr...· 0 citations
Genetic evidence supporting a causal role for depression in the etiology of late-onset AD is provided, a link not observed for other major psychiatric disorders tested and highlighted the specific importance of managing depression as a potential strategy for mitigating AD risk.
This MR study supported diabetes liability and higher alcohol intake as causal risk factors for DD, whereas genetically proxied obesity and smoking traits showed no clear causal effects, suggesting that better glycemic management and lower alcohol exposure may help reduce the risk of DD.
Heng Tian, Ling Hong, Wenlai Guo et al.· Korean Journal of Family Med...· 0 citations
Background Epidemiological studies have documented an association between allergic rhinitis (AR) and depression (DE), but causal interpretation is limited by confounding and reverse causation. We applied bidirectional two-sample Mendelian randomization to assess the direction and magnitude of this association and to ex...
Shao-Jie Zhang, Rong Wang, Jing-Jin Weng et al.· The World Allergy Organizati...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.